Literature DB >> 25830016

Treatment-related acute myeloid leukemia in a chronic lymphocytic leukemia patient: role of fludarabine?

Smith Giri1, Vijaya Raj Bhatt2, Sumesh Khanal3, Apar Kishor Ganti4.   

Abstract

Entities:  

Year:  2015        PMID： 25830016      PMCID： PMC4365054          DOI： 10.1177/2040620714566567

Source DB:  PubMed          Journal:  Ther Adv Hematol        ISSN： 2040-6207


× No keyword cloud information.
  21 in total

Review 1.  Acute myeloid leukemia with T-cell receptor gamma gene rearrangement occurring in a patient with chronic lymphocytic leukemia: a case report.

Authors:  Hassan A Hatoum; Rami A R Mahfouz; Zaher K Otrock; Abdel-Rahman Hudaib; Ali T Taher; Ali I Shamseddine
Journal:  Am J Hematol       Date:  2007-01       Impact factor: 10.047

2.  Coexistence of myelodysplastic syndrome and untreated chronic lymphocytic leukemia with development of acute myeloid leukemia immediately after treatment of chronic lymphocytic leukemia.

Authors:  A W Bracey; A M Maddox; L Immken; S M Hsu; M E Marks
Journal:  Am J Hematol       Date:  1989-03       Impact factor: 10.047

3.  Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.

Authors:  Chuanyi M Lu; Joyce L Murata-Collins; Endi Wang; Imran Siddiqi; H Jeffrey Lawrence
Journal:  Am J Hematol       Date:  2006-12       Impact factor: 10.047

4.  Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.

Authors:  J Waterman; L Rybicki; B Bolwell; E Copelan; B Pohlman; J Sweetenham; R Dean; R Sobecks; S Andresen; M Kalaycio
Journal:  Bone Marrow Transplant       Date:  2011-05-16       Impact factor: 5.483

5.  Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.

Authors:  Clarence C K Lam; Edmond S K Ma; Yok-Lam Kwong
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

Review 6.  Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).

Authors:  S Kempin; B J Lee; H T Thaler; B Koziner; S Hecht; T Gee; Z Arlin; C Little; D Straus; L Reich; E Phillips; H Al-Mondhiry; M Dowling; K Mayer; B Clarkson
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

7.  Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.

Authors:  Vicki A Morrison; Kanti R Rai; Bercedis L Peterson; Jonathan E Kolitz; Laurence Elias; Frederick R Appelbaum; John D Hines; Lois Shepherd; Richard A Larson; Charles A Schiffer
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

8.  Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.

Authors:  Nicole F Velez; Pritesh S Karia; Alexander R Vartanov; Matthew S Davids; Jennifer R Brown; Chrysalyne D Schmults
Journal:  JAMA Dermatol       Date:  2014-03       Impact factor: 10.282

9.  Second cancers in patients with chronic lymphocytic leukemia.

Authors:  L B Travis; R E Curtis; B F Hankey; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1992-09-16       Impact factor: 13.506

10.  Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia.

Authors:  Tae Sung Park; June-Won Cheong; Jaewoo Song; Jong Rak Choi
Journal:  Leuk Res       Date:  2009-01-19       Impact factor: 3.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.